HansBiomed Corporation (KOSDAQ:042520)
8,100.00
-30.00 (-0.37%)
Feb 12, 2025, 9:00 AM KST
HansBiomed Revenue
HansBiomed had revenue of 19.88B KRW in the quarter ending December 31, 2024, a decrease of -2.38%. This brings the company's revenue in the last twelve months to 80.65B, up 2.98% year-over-year. In the fiscal year ending September 30, 2024, HansBiomed had annual revenue of 81.14B with 3.98% growth.
Revenue (ttm)
80.65B
Revenue Growth
+2.98%
P/S Ratio
1.34
Revenue / Employee
635.07M
Employees
127
Market Cap
108.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 81.14B | 3.11B | 3.98% |
Sep 30, 2023 | 78.03B | 3.57B | 4.80% |
Sep 30, 2022 | 74.46B | 15.36B | 25.99% |
Sep 30, 2021 | 59.10B | -21.00B | -26.22% |
Sep 30, 2020 | 80.10B | 13.11B | 19.57% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |